Position in MDWD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$210,557
-$30,715 QoQ
Shares Held
13,070
0.0% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MDWD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026J. Goldman & Co LP holds $186,196,918 across 52 Biotechnology names. MDWD ranks #49 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COGT |
Cogent Biosciences, Inc.
|
779,570 | $30,005,649 | |
| 2 | ARDX |
Ardelyx, Inc.
|
3,000,513 | $17,973,072 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
235,260 | $17,665,673 | |
| 4 | URGN |
UroGen Pharma Ltd.
|
938,870 | $16,880,882 | |
| 5 | CAPR |
Capricor Therapeutics, Inc.
|
541,522 | $16,462,268 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,268 | $12,569,307 | |
| 7 | VSTM |
Verastem, Inc.
|
1,680,752 | $8,907,985 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
15,664 | $5,046,784 |
All Filings in MDWD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $210,557 | 13,070 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $241,272 | 13,070 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $235,521 | 13,070 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $253,165 | 13,070 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $202,846 | 13,070 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,049,683 | 58,971 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,065,016 | 58,971 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||